Effects Of Prednisolone On Rheumatoid Arthritis Patients
NCT00330889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2012-10-22
Summary
This study will assess the Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of Prednisolone on Rheumatoid Arthritis (RA) patients.
Conditions
- Arthritis, Rheumatoid
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 25 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-02-29
- Primary Completion
- 2006-12-31
- Completion
- 2006-12-31
Countries
- United States
- Canada
- United Kingdom
Study Locations
More Related Trials
-
The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study
NCT02585258 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis
NCT01395251 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis
NCT00976599 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days.
NCT00379990 ·Status: COMPLETED ·Phase: PHASE2
-
Difference in GC-induced Adrenal Insufficiency in RA Related to Polymorphisms in the Glucocorticoid Receptor Gene
NCT01411046 ·Status: UNKNOWN
-
Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550
NCT00414661 ·Status: COMPLETED
-
Very Low Dose Prednisolone on Newly Diagnosed Rheumatoid Arthritis
NCT07252271 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00505089 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis
NCT06880146 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)
NCT00256919 ·Status: COMPLETED ·Phase: PHASE2
-
Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica Patients
NCT01169597 ·Status: COMPLETED ·Phase: PHASE4
-
Circadian RA Study in Rheumatoid Arthritis Subjects
NCT03178955 ·Status: WITHDRAWN
-
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD
NCT05936970 ·Status: RECRUITING
-
Takayasu Arteritis Clinical Trial in China
NCT02981979 ·Status: COMPLETED ·Phase: NA
-
A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
NCT00713544 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients
NCT01328522 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX
NCT01039688 ·Status: COMPLETED ·Phase: PHASE3
-
Ancillary Study to Protocol 20060104
NCT00439894 ·Status: COMPLETED
-
Treatment for Subjects With Active Rheumatoid Arthritis (RA)
NCT00110903 ·Status: COMPLETED ·Phase: PHASE3
-
Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
NCT02202395 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
NCT00004686 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis
NCT00626275 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Longitudinal Effects of Intra-articular Corticosteroid Injection on Synovial Fluid Oxygen
NCT04804449 ·Status: COMPLETED
-
Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis
NCT06998628 ·Status: RECRUITING ·Phase: PHASE2